Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-functioning pituitary carcinoma.

Petra Nadja Elsässer Imboden1, François-Xavier Borruat2, Nicolas De Tribolet3

  • 1Service of Endocrinology, Diabetology and Metabolism, Department of Internal Medicine, University Hospital, Lausanne, Switzerland.

Pituitary
|July 13, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy.

Tremor and other hyperkinetic movements (New York, N.Y.)·2024
Same author

Susac Syndrome: A Case Series.

Klinische Monatsblatter fur Augenheilkunde·2022
Same author

When Two-Colour Dark Adaptometry is More Sensitive than Full-Field Electroretinogram in Detecting Vitamin A Deficiency - A Case Report.

Klinische Monatsblatter fur Augenheilkunde·2022
Same author

Long-term prognosis of patients with idiopathic Horner syndrome.

Journal of neurology·2021
Same author

Author's Rebuttal.

Klinische Monatsblatter fur Augenheilkunde·2021
Same author

Case Report: Multimodal Imaging of Toxic Retinopathies Related to Human Immunodeficiency Virus Antiretroviral Therapies: Maculopathy vs. Peripheral Retinopathy. Report of Two Cases and Review of the Literature.

Frontiers in neurology·2021
Same journal

Clinician decision-making in non-functioning pituitary adenomas: an Australian and New Zealand interdisciplinary survey study.

Pituitary·2026
Same journal

Does persistent hyperprolactinemia contribute to bone loss independently of estrogen deficiency in postmenopausal women?

Pituitary·2026
Same journal

Gauze swabbing technique for safe dissection of pituitary tumors.

Pituitary·2026
Same journal

Postoperative changes in circulating brain injury biomarkers in relation to long-term fatigue and cognitive outcomes after surgery for nonfunctioning pituitary adenomas.

Pituitary·2026
Same journal

Pituitary metastasis as an endocrine-neuro-ophthalmologic emergency: clinical red flags and outcomes from a contemporary tertiary-center series.

Pituitary·2026
Same journal

GH responsiveness to corticotropin-releasing hormone identifies corticotroph-like somatotroph adenomas in acromegaly.

Pituitary·2026
See all related articles
This summary is machine-generated.

Null-cell pituitary carcinomas are rare, aggressive tumors. This case highlights their poor prognosis, emphasizing the need for aggressive treatment despite diagnostic challenges.

Area of Science:

  • Endocrinology
  • Oncology
  • Neuropathology

Background:

  • Null-cell pituitary tumors are exceedingly rare adenohypophyseal neoplasms.
  • Distinguishing benign adenomas from malignant carcinomas at initial presentation is challenging.
  • Nonfunctioning pituitary tumors lack specific endocrine symptoms, often presenting with mass effect.

Observation:

  • A 41-year-old woman presented with a large, nonfunctioning pituitary neoplasm causing mass effect.
  • Rapidly progressive ocular motility disorders and anterior pituitary failure developed.
  • Histopathology revealed a null cell tumor with a high mitotic index, raising suspicion for carcinoma due to rapid relapse.

Findings:

  • The patient underwent trans-sphenoidal surgery and radiotherapy (59.4 Gy).

Related Experiment Videos

  • Initial tumor reduction and improvement in ocular motility were observed.
  • Despite treatment, the patient rapidly declined and died of carcinomatous meningitis within 7 months.

    • Implications:

    • This case underscores the poor prognosis associated with nonfunctioning pituitary carcinomas.
    • Aggressive surgical and radiotherapeutic approaches are recommended.
    • Further research is needed to improve diagnostic criteria and treatment strategies for these rare malignancies.